Literature DB >> 15531532

Plasma levels of intact and degraded ghrelin and their responses to glucose infusion in anorexia nervosa.

Mari Hotta1, Rina Ohwada, Hideki Katakami, Tamotsu Shibasaki, Naomi Hizuka, Kazue Takano.   

Abstract

Octanoylated ghrelin (1-28) (intact ghrelin) is rapidly and easily degraded to desoctanoyl forms or smaller fragments (degraded ghrelin). Plasma levels of intact and degraded ghrelin were examined in 30 patients with anorexia nervosa (AN) (body mass index, 8.81-22.4 kg/m(2)) and 16 age-matched healthy women using several assay methods. Plasma levels of ghrelin measured using immunocomplex transfer-enzyme immunoassay, which specifically detects intact ghrelin, were lower in AN than controls. Plasma ghrelin levels in AN measured using the active ghrelin ELISA kit, which is advertised as specifically detecting intact ghrelin, did not differ significantly from controls. Plasma levels of desoctanoyl ghrelin using the desacyl-ghrelin ELISA kit, N-terminus ghrelin using the ghrelin active RIA kit, and C-terminus ghrelin using the ghrelin total RIA kit were significantly higher in AN than controls, and displayed significant negative correlations with body mass index. Plasma levels of ghrelin determined using immunocomplex transfer-enzyme immunoassay or active ghrelin ELISA during iv glucose infusion were suppressed in both AN and controls, whereas plasma levels of degraded ghrelin levels were not significantly decreased in AN. Plasma levels of intact ghrelin are therefore not higher in AN than controls, whereas degraded forms of ghrelin are elevated in AN. Rapid suppression of plasma intact ghrelin, but not degraded ghrelin, occurs in AN in response to glucose infusion. The profiles of intact and degraded forms of ghrelin in plasma of AN patients differ from those of healthy women.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15531532     DOI: 10.1210/jc.2004-0353

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  28 in total

Review 1.  Central dysregulations in the control of energy homeostasis and endocrine alterations in anorexia and bulimia nervosa.

Authors:  A Torsello; F Brambilla; L Tamiazzo; I Bulgarelli; D Rapetti; E Bresciani; V Locatelli
Journal:  J Endocrinol Invest       Date:  2007-12       Impact factor: 4.256

2.  Somatic and psychological factors related to the body mass index of patients with anorexia nervosa.

Authors:  K Kawai; T Yamanaka; S Yamashita; M Gondo; C Morita; C Arimura; T Nozaki; M Takii; C Kubo
Journal:  Eat Weight Disord       Date:  2008-12       Impact factor: 4.652

3.  Low bone mineral density in anorexia nervosa: Treatments and challenges.

Authors:  Pouneh K Fazeli
Journal:  Clin Rev Bone Miner Metab       Date:  2019-04-15

Review 4.  The ghrelin axis in disease: potential therapeutic indications.

Authors:  Ralf Nass; Bruce D Gaylinn; Michael O Thorner
Journal:  Mol Cell Endocrinol       Date:  2011-02-25       Impact factor: 4.102

5.  Glucose metabolism during ghrelin infusion in patients with anorexia nervosa.

Authors:  D Miljic; M Djurovic; S Pekic; M Doknic; M Stojanovic; N Milic; F F Casanueva; M Ghatei; V Popovic
Journal:  J Endocrinol Invest       Date:  2007-10       Impact factor: 4.256

6.  Novel ghrelin assays provide evidence for independent regulation of ghrelin acylation and secretion in healthy young men.

Authors:  Jianhua Liu; Catherine E Prudom; Ralf Nass; Suzan S Pezzoli; Mary C Oliveri; Michael L Johnson; Paula Veldhuis; David A Gordon; Andrew D Howard; Derrick R Witcher; H Mario Geysen; Bruce D Gaylinn; Michael O Thorner
Journal:  J Clin Endocrinol Metab       Date:  2008-03-18       Impact factor: 5.958

7.  Ghrelin and obestatin levels in rheumatoid arthritis.

Authors:  Suleyman Serdar Koca; Metin Ozgen; Suleyman Aydin; Sait Dag; Bahri Evren; Ahmet Isik
Journal:  Inflammation       Date:  2008-10       Impact factor: 4.092

Review 8.  Ghrelin and eating disorders.

Authors:  Deniz Atalayer; Charlisa Gibson; Alexandra Konopacka; Allan Geliebter
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-08-30       Impact factor: 5.067

9.  Ghrelin differentially affects hepatic and peripheral insulin sensitivity in mice.

Authors:  A C Heijboer; A M van den Hoek; E T Parlevliet; L M Havekes; J A Romijn; H Pijl; E P M Corssmit
Journal:  Diabetologia       Date:  2006-02-17       Impact factor: 10.122

10.  A non-acromegalic case of multiple endocrine neoplasia type 1 accompanied by a growth hormone-releasing hormone-producing pancreatic tumor.

Authors:  H Sugihara; T Shibasaki; A Tatsuguchi; F Okajima; S Wakita; Y Nakajima; K Tanimura; H Tamura; S Ishii; J Kamegai; H Akasu; W Kitagawa; K Shimizu; Y Nakamura; E Uchida; T Tajiri; Z Naito; H Katakami; S Oikawa
Journal:  J Endocrinol Invest       Date:  2007-05       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.